Article

PDF
Access to the PDF text
Advertising



Archives of cardiovascular diseases
Volume 110, n° 11
pages 626-633 (novembre 2017)
Doi : 10.1016/j.acvd.2016.12.017
Received : 2 October 2016 ;  accepted : 22 December 2016
Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
Impact du niveau d’inhibition plaquettaire sur la survenue du no-reflow chez les patients admis pour syndrome coronaire aigu avec sus-décalage du segment ST qui vont bénéficier d’un traitement par angioplastie primaire
 

Figure 1




Figure 1 : 

Mean platelet reactivity in no-reflow and normal flow groups.


Figure 2




Figure 2 : 

Receiver operating characteristic (ROC) analysis determining the VerifyNow® cut-off value predicting no-reflow. AUC: area under the curve.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline